journal article·2026-03Open access

Metformin‐Based Covalent Organic Frameworks With Excellent Biosafety and High Efficiency against Pathogenic Microorganisms

Jia‐Yi Liu, Hong Jiang, Lei Ma, Jin‐Yi Yu, Ming‐Yi Yang, Hao‐Ru Wang, Jun‐Yuang Tang, Shengfeng Huang, Wei Yi, Meng Lu, Ya‐Qian Lan, Xu‐Jia Hong

Advanced Science· Volume 13· Issue 14

Abstract

ABSTRACT The escalating public health security crisis caused by pathogenic microorganisms and the worsening antibiotic resistance urgently demand the development of antimicrobial materials with high efficiency and safety. Covalent organic frameworks (COFs) exhibit significant potential in photocatalytic antibacterial applications, but face challenges such as insufficient biosafety and difficulties in application translation. In this work, we first report two metformin‐based photoactive cationic MCOFs engineered for synergistic functionality and safety. They exhibit broad‐spectrum light absorption, efficient charge separation, and generate multiple ROS via Type I/II photodynamic, achieving >99 % inactivation of bacteria/viruses. Excellent biocompatibility with LD 50 >5000 mg/kg is confirmed. Mechanistic studies based on molecular dynamics (MD) simulation and transcriptome results revealed a triple synergistic antibacterial pathway involving membrane targeting, ROS attack, and metabolic interference. Furthermore, we fabricated a COF/thermoplastic polyurethane (TPU) composite functional membrane, which exhibits >99 % antibacterial and antiviral efficiency, along with a notable 98.3 % inhibition rate against methicillin‐resistant Staphylococcus aureus (MRSA). This study not only provides a new design strategy for MCOFs with synergistically enhanced functionality and biosafety, but also offers a promising material platform for biomedical applications such as anti‐infection protection, wound healing, and the treatment of drug‐resistant bacterial infections.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Covalent Organic Framework Applications · Advanced Photocatalysis Techniques · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology the NMPA and State Key Laboratory of Respiratory Disease School of Pharmaceutical Sciences Guangzhou Medical University Guangzhou P. R. China

Guangdong Provincial Key Laboratory of Carbon Dioxide Resource Utilization School of Chemistry South China Normal University Guangzhou P. R. China

State Key Laboratory of Respiratory Disease National Clinical Research Center for Respiratory Disease Guangzhou Institute of Respiratory Health National Center for Respiratory Medicine The First Affiliated Hospital of Guangzhou Medical University Guangzhou P. R. China

The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou P. R. China

Funding

Natural Science Foundation of Guangdong Province · National Natural Science Foundation of China · Basic and Applied Basic Research Foundation of Guangdong Province

References (38)

Show source-provided references
1. 10.1126/science.abd914910.1126/science.abd9149 ↗
2. 10.1038/s41591-020-0843-210.1038/s41591-020-0843-2 ↗
3. 10.1038/nrmicro.2017.4210.1038/nrmicro.2017.42 ↗
4. 10.1126/science.aat058610.1126/science.aat0586 ↗
5. 10.1038/d41586‐020‐02884‐310.1038/d41586‐020‐02884‐3 ↗
6. 10.1126/science.aau467910.1126/science.aau4679 ↗
7. 10.1016/j.drup.2022.10089010.1016/j.drup.2022.100890 ↗
8. 10.1021/acs.chemrev.3c0032610.1021/acs.chemrev.3c00326 ↗
9. 10.1039/D2CS00460G10.1039/D2CS00460G ↗
10. 10.1038/s41467‐019‐10218‐910.1038/s41467‐019‐10218‐9 ↗
11. 10.1016/j.apcatb.2012.05.03610.1016/j.apcatb.2012.05.036 ↗
12. 10.1002/jccs.20160073510.1002/jccs.201600735 ↗
13. 10.1021/jacs.2c0306010.1021/jacs.2c03060 ↗
14. 10.1021/acs.accounts.1c0069310.1021/acs.accounts.1c00693 ↗
15. 10.1016/j.ccr.2024.21642410.1016/j.ccr.2024.216424 ↗
16. 10.1002/adma.20231151910.1002/adma.202311519 ↗
17. 10.1039/D1TA08743F10.1039/D1TA08743F ↗
18. 10.1021/acsnano.2c1133910.1021/acsnano.2c11339 ↗
19. 10.1002/adfm.20231084510.1002/adfm.202310845 ↗
20. 10.1002/anie.20251375410.1002/anie.202513754 ↗
21. 10.1021/acsnano.3c1162810.1021/acsnano.3c11628 ↗
22. 10.1021/jacs.5b1353310.1021/jacs.5b13533 ↗
23. 10.1002/anie.20191236310.1002/anie.201912363 ↗
24. 10.1002/smll.20210075610.1002/smll.202100756 ↗
25. 10.1002/adfm.20200204610.1002/adfm.202002046 ↗
26. 10.1021/acsnano.2c1134610.1021/acsnano.2c11346 ↗
27. 10.1039/D3CC04368A10.1039/D3CC04368A ↗
28. 10.1038/nature0809710.1038/nature08097 ↗
29. 10.1016/j.xcrm.2025.10194110.1016/j.xcrm.2025.101941 ↗
30. 10.1016/j.cell.2024.08.02110.1016/j.cell.2024.08.021 ↗
31. 10.1038/s41598‐021‐98223‐110.1038/s41598‐021‐98223‐1 ↗
32. 10.1021/acsnano.1c1104010.1021/acsnano.1c11040 ↗
33. 10.1007/s12274‐022‐4457‐510.1007/s12274‐022‐4457‐5 ↗
34. 10.1021/acsnano.3c1162810.1021/acsnano.3c11628 ↗
35. 10.1002/adfm.20240061310.1002/adfm.202400613 ↗
36. 10.1002/adma.20230038010.1002/adma.202300380 ↗
37. 10.1016/j.pmatsci.2025.10153210.1016/j.pmatsci.2025.101532 ↗
38. 10.1007/s12598‐024‐02797‐410.1007/s12598‐024‐02797‐4 ↗